TBPH
Theravance Biopharma, Inc.
Company overview
- Market capitalization
- $884.18M
- Employees
- 90
- Latest publication
- 2026-09-29
About Theravance Biopharma, Inc.
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17,699,000USD | 45,891,000USD | 19,990,000USD | 26,195,000USD | 15,388,000USD | 18,754,000USD | 16,868,000USD | 14,256,000USD |
| Cost Of Revenue | 1,437,000USD | 1,506,000USD | 8,112,000USD | 10,490,000USD | 11,452,000USD | 1,365,000USD | 9,268,000USD | 9,954,000USD |
| Gross Profit | 16,262,000USD | 44,385,000USD | 11,878,000USD | 15,705,000USD | 3,936,000USD | 18,754,000USD | 7,600,000USD | 4,302,000USD |
| Research Development | 5,829,000USD | 6,963,000USD | 8,112,000USD | 10,490,000USD | 11,452,000USD | 9,453,000USD | 9,268,000USD | 9,954,000USD |
| Selling General Administrative | 17,720,000USD | 18,520,000USD | 18,333,000USD | 18,430,000USD | 18,370,000USD | 14,201,000USD | 16,875,000USD | 17,056,000USD |
| Unclassified Operating Expenses | 1,010,000USD | 1,337,000USD | -8,112,000USD | -10,490,000USD | -11,452,000USD | — | -7,706,000USD | -7,003,000USD |
| Total Operating Expenses | 24,559,000USD | 26,820,000USD | 18,333,000USD | 18,430,000USD | 18,370,000USD | 27,954,000USD | 18,437,000USD | 20,007,000USD |
| Operating Income | -8,297,000USD | 17,565,000USD | -6,455,000USD | -2,725,000USD | -14,434,000USD | -9,200,000USD | -10,837,000USD | -15,705,000USD |
| Interest Income | 3,013,000USD | 3,639,000USD | 4,139,000USD | 1,457,000USD | 939,000USD | 904,000USD | 1,415,000USD | 1,128,000USD |
| Interest Expense | 0USD | 583,000USD | 573,000USD | 663,000USD | 643,000USD | 643,000USD | 630,000USD | 644,000USD |
| Net Interest Income | 3,013,000USD | 3,057,000USD | 3,566,000USD | 794,000USD | 296,000USD | 261,000USD | 785,000USD | 484,000USD |
| Income Before Tax | -6,470,000USD | 73,069,000USD | -2,889,000USD | 73,206,000USD | -14,138,000USD | -8,939,000USD | -10,052,000USD | -15,221,000USD |
| Income Tax Expense | -1,537,000USD | 12,044,000USD | -6,504,000USD | 18,371,000USD | -559,000USD | 6,588,000USD | 2,646,000USD | 1,308,000USD |
| Tax Provision | -1,537,000USD | 12,044,000USD | -6,504,000USD | 18,371,000USD | -559,000USD | 6,588,000USD | 2,646,000USD | 1,308,000USD |
| Net Income | -4,933,000USD | 61,024,000USD | 3,615,000USD | 54,835,000USD | -13,579,000USD | -15,527,000USD | -12,698,000USD | -16,529,000USD |
| Net Income From Continuing Ops | -4,933,000USD | 61,024,000USD | 3,615,000USD | 54,835,000USD | -13,579,000USD | -15,527,000USD | -12,698,000USD | -16,529,000USD |
| Ebit | -8,297,000USD | 17,565,000USD | -2,316,000USD | -2,725,000USD | -14,434,000USD | -8,296,000USD | -9,275,000USD | -12,754,000USD |
| Ebitda | -6,860,000USD | 19,071,000USD | -1,907,000USD | -2,316,000USD | -14,021,000USD | -7,601,000USD | -8,846,000USD | -12,327,000USD |
| Depreciation And Amortization | 1,437,000USD | 1,506,000USD | 409,000USD | 409,000USD | 413,000USD | 695,000USD | 429,000USD | 427,000USD |
| Reconciled Depreciation | 835,000USD | 196,000USD | 636,000USD | 927,000USD | 1,052,000USD | 695,000USD | 762,000USD | 979,000USD |
| Total Other Income Expense Net | 1,827,000USD | 55,504,000USD | 3,566,000USD | 75,931,000USD | 296,000USD | 261,000USD | 785,000USD | 484,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 4,300,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 107,464,000USD | 64,381,000USD | 57,424,000USD | 51,346,000USD | 55,311,000USD | 71,857,000USD | 73,414,000USD | 60,370,000USD |
| Cost Of Revenue | 5,515,000USD | 6,014,000USD | 40,621,000USD | 63,392,000USD | 193,657,000USD | 260,953,000USD | 219,248,000USD | 715,000USD |
| Gross Profit | 101,949,000USD | 64,381,000USD | 16,803,000USD | -12,046,000USD | -138,346,000USD | 71,857,000USD | 73,414,000USD | 59,655,000USD |
| Research Development | 37,414,000USD | 37,643,000USD | 46,344,000USD | 70,074,000USD | 201,548,000USD | 260,953,000USD | 219,248,000USD | 201,348,000USD |
| Selling General Administrative | 73,652,000USD | 64,874,000USD | 65,352,000USD | 59,072,999USD | 99,296,000USD | 108,661,000USD | 106,081,000USD | 97,058,000USD |
| Unclassified Operating Expenses | 4,129,000USD | 4,513,000USD | -38,858,000USD | -49,235,999USD | -181,406,000USD | — | — | — |
| Total Operating Expenses | 115,195,000USD | 111,330,000USD | 72,838,000USD | 79,911,000USD | 119,438,000USD | 369,484,000USD | 325,329,000USD | 298,406,000USD |
| Operating Income | -13,246,000USD | -46,949,000USD | -56,035,000USD | -91,957,000USD | -257,784,000USD | -297,627,000USD | -251,915,000USD | -238,751,000USD |
| Interest Income | 10,173,000USD | 4,881,000USD | 10,991,000USD | 8,545,000USD | 1,109,000USD | 2,831,000USD | 8,395,000USD | 11,966,000USD |
| Interest Expense | 2,461,000USD | 2,546,000USD | 2,350,000USD | 6,369,000USD | 8,547,000USD | 8,547,000USD | 31,862,000USD | 10,482,000USD |
| Net Interest Income | 7,712,000USD | 2,335,000USD | 8,714,000USD | 2,176,000USD | -45,780,000USD | -41,754,000USD | -23,467,000USD | 1,484,000USD |
| Income Before Tax | 129,247,000USD | -44,614,000USD | -49,269,000USD | -92,815,000USD | -265,221,999USD | -303,343,000USD | -241,677,000USD | -226,085,000USD |
| Income Tax Expense | 23,352,000USD | 11,804,000USD | 5,924,000USD | 9,000USD | -151,000USD | -8,520,000USD | -5,222,000USD | -10,561,000USD |
| Tax Provision | 23,352,000USD | 11,804,000USD | 2,427,000USD | 9,000USD | -151,000USD | -8,520,000USD | -5,222,000USD | -10,561,000USD |
| Net Income | 105,895,000USD | -56,418,000USD | -55,193,000USD | 872,132,000USD | -199,426,000USD | -278,017,000USD | -236,455,000USD | -215,524,000USD |
| Net Income From Continuing Ops | 105,895,000USD | -56,418,000USD | -60,939,000USD | -92,824,000USD | -199,426,000USD | -278,017,000USD | -236,455,000USD | -215,524,000USD |
| Ebit | -13,246,000USD | -42,068,000USD | -53,649,000USD | -79,119,000USD | -237,642,000USD | -294,796,000USD | -209,815,000USD | -215,603,000USD |
| Ebitda | -7,731,000USD | -38,453,000USD | -51,648,000USD | -76,084,000USD | -232,830,000USD | -287,824,000USD | -203,601,000USD | -212,437,000USD |
| Depreciation And Amortization | 5,515,000USD | 3,615,000USD | 2,001,000USD | 3,035,000USD | 4,812,000USD | 6,972,000USD | 6,214,000USD | 3,166,000USD |
| Reconciled Depreciation | 2,811,000USD | 3,615,000USD | 4,864,000USD | 7,024,000USD | 9,708,000USD | 9,063,000USD | 6,214,000USD | 3,166,000USD |
| Total Other Income Expense Net | 142,493,000USD | 2,335,000USD | 6,766,000USD | -858,000USD | -7,437,999USD | -5,716,000USD | 10,238,000USD | 12,666,000USD |
| Selling And Marketing Expenses | — | 4,300,000USD | — | — | — | — | — | — |
| Non Operating Income Net Other | — | — | — | 5,511,000USD | 105,096,000USD | 55,805,000USD | 42,100,000USD | 23,148,000USD |
| Discontinued Operations | — | — | — | 964,956,000USD | 65,645,000USD | 16,806,000USD | 16,806,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | 872,132,000USD | -199,426,000USD | -278,017,000USD | -236,455,000USD | -215,524,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 472,313,000USD | 485,570,000USD | 415,460,000USD | 426,035,000USD | 343,582,000USD | 354,161,000USD | 356,105,000USD | 362,029,000USD |
| Other Current Assets | 7,384,000USD | 7,564,000USD | 6,750,000USD | 5,571,000USD | 4,056,000USD | 4,277,000USD | 8,274,000USD | 8,930,000USD |
| Total Liab | 181,719,000USD | 188,847,000USD | 182,779,000USD | 201,187,000USD | 177,599,000USD | 178,616,000USD | 170,451,000USD | 168,340,000USD |
| Total Stockholder Equity | 290,594,000USD | 296,723,000USD | 232,681,000USD | 224,848,000USD | 165,983,000USD | 175,545,000USD | 185,654,000USD | 193,689,000USD |
| Other Current Liab | 19,923,000USD | 24,789,000USD | 24,280,000USD | 15,366,000USD | 12,434,000USD | 13,278,000USD | 17,785,000USD | 17,053,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | — | — | 193,689,000USD |
| Capital Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 0USD | 0USD | 0USD |
| Retained Earnings | -864,560,000USD | -859,627,000USD | -920,651,000USD | -924,266,000USD | -979,101,000USD | -965,522,000USD | -949,995,000USD | -937,297,000USD |
| Cash | 288,101,000USD | 167,806,000USD | 174,773,000USD | 281,927,000USD | 110,614,000USD | 37,797,000USD | 23,378,000USD | 46,345,000USD |
| Cash And Short Term Investments | 394,666,000USD | 315,357,000USD | 329,680,000USD | 338,804,000USD | 130,855,000USD | 88,350,000USD | 91,361,000USD | 96,078,000USD |
| Total Current Assets | 417,634,000USD | 418,460,000USD | 354,697,000USD | 366,294,000USD | 150,264,000USD | 161,067,000USD | 116,480,000USD | 119,307,000USD |
| Total Current Liabilities | 31,775,000USD | 38,302,000USD | 37,407,000USD | 54,633,000USD | 31,502,000USD | 32,085,000USD | 23,435,000USD | 22,946,000USD |
| Net Debt | -214,802,000USD | -92,308,000USD | -130,178,000USD | -235,470,000USD | -62,458,000USD | 12,023,000USD | 21,603,000USD | 315,000USD |
| Short Term Debt | 10,752,000USD | 10,945,000USD | 10,914,000USD | 10,896,000USD | 10,807,000USD | 10,712,000USD | 4,196,000USD | 4,219,000USD |
| Short Long Term Debt Total | 73,299,000USD | 75,498,000USD | 44,595,000USD | 46,457,000USD | 48,156,000USD | 49,820,000USD | 44,981,000USD | 46,660,000USD |
| Long Term Investments | 0USD | 11,128,000USD | 3,029,000USD | — | — | 0USD | — | — |
| Short Term Investments | 106,565,000USD | 147,551,000USD | 154,907,000USD | 56,877,000USD | 20,241,000USD | 50,553,000USD | 67,983,000USD | 49,733,000USD |
| Net Receivables | 15,584,000USD | 95,539,000USD | 18,267,000USD | 21,919,000USD | 15,353,000USD | 68,440,000USD | 16,845,000USD | 14,299,000USD |
| Accounts Payable | 1,100,000USD | 2,568,000USD | 2,213,000USD | 1,675,000USD | 2,408,000USD | 2,242,000USD | 1,454,000USD | 1,674,000USD |
| Property Plant Equipment Net | 28,540,000USD | 30,266,000USD | 31,707,000USD | 33,134,000USD | 34,458,000USD | 35,772,000USD | 37,122,000USD | 39,957,000USD |
| Property Plant Equipment Gross | 28,540,000USD | 54,087,000USD | 31,707,000USD | 33,134,000USD | 34,458,000USD | 58,173,000USD | 37,122,000USD | 39,957,000USD |
| Accumulated Other Comprehensive Income | -62,000USD | 61,000USD | 32,000USD | -10,000USD | — | 7,000USD | 50,000USD | -22,000USD |
| Common Stock Shares Outstanding | 51,279,000shares | 53,053,000shares | 51,908,000shares | 50,726,000shares | 49,706,000shares | 49,306,000shares | 49,038,000shares | 48,747,000shares |
| Non Current Assets Total | 54,679,000USD | 67,110,000USD | 60,763,000USD | 59,741,000USD | 193,318,000USD | 193,094,000USD | 239,625,000USD | 242,722,000USD |
| Non Current Liabilities Total | 149,944,000USD | 150,545,000USD | 145,372,000USD | 146,554,000USD | 146,097,000USD | 146,531,000USD | 147,016,000USD | 145,394,000USD |
| Non Current Liabilities Other | 33,039,000USD | 33,108,000USD | 32,526,000USD | 33,188,000USD | 32,264,000USD | 32,224,000USD | 34,668,000USD | 33,946,000USD |
| Non Currrent Assets Other | 25,303,000USD | 22,499,000USD | 26,027,000USD | 26,607,000USD | 158,860,000USD | 157,322,000USD | 202,503,000USD | 202,765,000USD |
| Net Working Capital | 385,859,000USD | 380,158,000USD | 317,290,000USD | 311,661,000USD | 118,762,000USD | 128,982,000USD | 93,045,000USD | 96,361,000USD |
| Unclassified Non Current Liabilities | 116,905,000USD | 117,437,000USD | 112,846,000USD | 113,366,000USD | 113,833,000USD | 114,307,000USD | 112,348,000USD | 111,448,000USD |
| Unclassified Equity | 1,155,214,000USD | 1,156,287,000USD | 1,153,298,000USD | 1,149,122,000USD | 1,145,082,000USD | 1,141,060,000USD | 1,135,599,000USD | 937,319,000USD |
| Unclassified Non Current Assets | — | 3,217,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | — | — | 26,696,000USD | 5,853,000USD | 5,853,000USD | — | — |
| Inventory | — | — | — | — | — | — | -17,442,000USD | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -5,893,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 485,570,000USD | 354,161,000USD | 381,999,000USD | 607,400,000USD | 374,819,000USD | 469,057,000USD | 408,826,000USD | 560,235,000USD |
| Other Current Assets | 7,564,000USD | 4,277,000USD | 13,641,000USD | 9,195,000USD | 18,806,000USD | 30,733,000USD | 7,087,000USD | 310,000USD |
| Total Liab | 188,847,000USD | 178,616,000USD | 169,004,000USD | 165,600,000USD | 713,392,000USD | 772,808,000USD | 632,666,000USD | 611,824,000USD |
| Total Stockholder Equity | 296,723,000USD | 175,545,000USD | 212,995,000USD | 441,800,000USD | -338,573,000USD | -303,751,000USD | -223,840,000USD | -51,589,000USD |
| Other Current Liab | 24,789,000USD | 13,278,000USD | 19,320,000USD | 20,384,000USD | 37,948,000USD | 76,072,000USD | 57,757,000USD | 46,124,000USD |
| Common Stock | 1,000USD | — | — | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 1,000USD | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -859,627,000USD | -965,522,000USD | -909,104,000USD | -853,911,000USD | -1,726,043,000USD | -1,526,617,000USD | -1,248,600,000USD | -1,012,145,000USD |
| Cash | 167,806,000USD | 37,797,000USD | 39,545,000USD | 298,172,000USD | 89,959,000USD | 81,467,000USD | 58,064,000USD | 378,021,000USD |
| Cash And Short Term Investments | 315,357,000USD | 88,350,000USD | 102,426,000USD | 327,484,000USD | 173,465,000USD | 292,941,000USD | 280,831,000USD | 505,276,000USD |
| Total Current Assets | 418,460,000USD | 161,067,000USD | 133,541,000USD | 353,464,000USD | 249,870,000USD | 393,341,000USD | 338,488,000USD | 532,823,000USD |
| Total Current Liabilities | 38,302,000USD | 32,085,000USD | 24,767,000USD | 28,715,000USD | 58,587,000USD | 123,571,000USD | 111,703,000USD | 98,554,000USD |
| Net Debt | -92,308,000USD | 12,023,000USD | 9,614,000USD | -246,012,000USD | 579,559,000USD | 594,790,000USD | 452,464,000USD | 76,332,000USD |
| Short Term Debt | 10,945,000USD | 10,712,000USD | 3,923,000USD | 6,753,000USD | 17,443,000USD | 29,201,000USD | 17,613,000USD | — |
| Short Long Term Debt Total | 75,498,000USD | 49,820,000USD | 49,159,000USD | 52,160,000USD | 669,518,000USD | 676,257,000USD | 510,528,000USD | 454,353,000USD |
| Long Term Investments | 11,128,000USD | 0USD | — | 0USD | 67,537,000USD | 12,750,000USD | 8,667,000USD | 11,869,000USD |
| Short Term Investments | 147,551,000USD | 50,553,000USD | 62,881,000USD | 29,312,000USD | 83,506,000USD | 211,474,000USD | 222,767,000USD | 127,255,000USD |
| Net Receivables | 95,539,000USD | 68,440,000USD | 17,474,000USD | 16,785,000USD | 57,599,000USD | 69,667,000USD | 50,570,000USD | 10,673,000USD |
| Accounts Payable | 2,568,000USD | 2,242,000USD | 1,524,000USD | 1,554,000USD | 3,098,000USD | 6,775,000USD | 4,758,000USD | 9,028,000USD |
| Property Plant Equipment Net | 30,266,000USD | 35,772,000USD | 45,355,000USD | 52,001,000USD | 53,347,000USD | 59,682,000USD | 59,248,000USD | 13,176,000USD |
| Property Plant Equipment Gross | 54,087,000USD | 58,173,000USD | 66,937,000USD | 52,001,000USD | 53,347,000USD | 16,422,000USD | 59,248,000USD | 13,176,000USD |
| Accumulated Other Comprehensive Income | 61,000USD | 7,000USD | -65,000USD | -15,000USD | 0USD | 47,000USD | 145,000USD | -166,000USD |
| Common Stock Shares Outstanding | 51,507,000shares | 48,847,000shares | 55,303,000shares | 73,591,000shares | 69,461,000shares | 62,345,000shares | 55,610,000shares | 53,969,000shares |
| Non Current Assets Total | 67,110,000USD | 193,094,000USD | 248,458,000USD | 253,936,000USD | 124,949,000USD | 75,716,000USD | 70,338,000USD | 27,412,000USD |
| Non Current Liabilities Total | 150,545,000USD | 146,531,000USD | 144,237,000USD | 136,885,000USD | 654,805,000USD | 649,237,000USD | 520,963,000USD | 513,270,000USD |
| Non Current Liabilities Other | 33,108,000USD | 32,224,000USD | 33,707,000USD | 1,657,000USD | 2,730,000USD | 1,833,000USD | 21,287,000USD | 24,762,000USD |
| Non Currrent Assets Other | 22,499,000USD | 157,322,000USD | 203,103,000USD | 201,935,000USD | 3,228,000USD | 15,201,000USD | 1,590,000USD | 2,367,000USD |
| Net Working Capital | 380,158,000USD | 128,982,000USD | 108,774,000USD | 324,749,000USD | 191,283,000USD | 269,770,000USD | 226,785,000USD | 434,269,000USD |
| Unclassified Non Current Assets | 3,217,000USD | — | — | -201,935,000USD | -3,228,000USD | -15,201,000USD | -5,272,000USD | -2,367,000USD |
| Unclassified Non Current Liabilities | 117,437,000USD | 114,307,000USD | 110,530,000USD | 43,750,000USD | 49,951,000USD | 418,260,000USD | 26,438,000USD | -32,738,000USD |
| Unclassified Equity | 1,156,287,000USD | 1,141,060,000USD | 1,122,164,000USD | 1,295,724,000USD | 1,387,468,000USD | 1,222,817,000USD | 1,024,613,000USD | 960,720,000USD |
| Inventory | — | -68,513,000USD | 1USD | 1,513,000USD | 10,245,000USD | 20,374,000USD | 1USD | 1USD |
| Unclassified Current Liabilities | — | 5,853,000USD | — | — | -16,940,000USD | -19,334,000USD | -9,851,000USD | — |
| Current Deferred Revenue | — | — | -5,447,000USD | 24,000USD | 98,000USD | 11,523,000USD | 31,575,000USD | 43,402,000USD |
| Other Liab | — | — | — | 91,478,000USD | 2,730,000USD | 2,181,000USD | 28,048,000USD | 58,917,000USD |
| Other Assets | — | — | — | 201,935,000USD | 4,065,000USD | 3,284,000USD | 6,105,000USD | 2,367,000USD |
| Net Tangible Assets | — | — | — | 577,028,000USD | -338,573,000USD | 116,690,000USD | -169,354,000USD | -25,410,000USD |
| Short Long Term Debt | — | — | — | — | 16,940,000USD | 19,334,000USD | 9,851,000USD | — |
| Long Term Debt | — | — | — | — | 599,394,000USD | 226,963,000USD | 445,190,000USD | 454,353,000USD |
| Unclassified Current Assets | — | — | — | — | -10,245,000USD | -20,374,000USD | — | 16,563,999USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 7,976,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,933,000USD | 61,024,000USD | 3,615,000USD | 54,835,000USD | -13,579,000USD | -15,527,000USD | -12,698,000USD | -16,529,000USD |
| Depreciation | 1,437,000USD | 430,000USD | 636,000USD | 927,000USD | 1,052,000USD | 695,000USD | 762,000USD | 979,000USD |
| Stock Based Compensation | 4,504,000USD | 4,480,000USD | 4,576,000USD | 4,543,000USD | 4,877,000USD | 5,826,000USD | 4,963,000USD | 5,375,000USD |
| Other Non Cash Items | 3,944,000USD | -333,698,000USD | 551,000USD | 664,000USD | 604,000USD | 806,000USD | 2,029,000USD | 3,629,000USD |
| Change To Account Receivables | 79,954,000USD | 99,608,000USD | 3,652,000USD | -6,566,000USD | 53,087,000USD | -1,595,000USD | -2,546,000USD | 365,000USD |
| Change In Working Capital | 75,830,000USD | 261,670,000USD | -16,880,000USD | 157,796,000USD | 51,937,000USD | 13,887,000USD | -342,000USD | 2,692,000USD |
| Total Cash From Operating Activities | 73,279,000USD | -6,064,000USD | -6,508,000USD | 208,074,000USD | 43,039,000USD | -902,000USD | -5,196,000USD | -4,415,000USD |
| Capital Expenditures | 0USD | -8,000USD | 0USD | -34,000USD | 0USD | -190,000USD | -15,000USD | -36,000USD |
| Free Cash Flow | 73,279,000USD | -6,072,000USD | -6,508,000USD | 208,040,000USD | 43,039,000USD | -1,092,000USD | -5,211,000USD | -4,451,000USD |
| Investments | 52,593,000USD | 596,000USD | -100,246,000USD | -36,258,000USD | 30,632,000USD | 15,686,000USD | -17,399,000USD | -3,031,000USD |
| Total Cashflows From Investing Activities | 52,593,000USD | 588,000USD | -100,246,000USD | -36,258,000USD | 30,632,000USD | 15,686,000USD | -17,399,000USD | -3,031,000USD |
| Total Cash From Financing Activities | -5,577,000USD | -1,491,000USD | -400,000USD | -503,000USD | -854,000USD | -365,000USD | -372,000USD | -44,000USD |
| Sale Purchase Of Stock | -5,818,000USD | -1,979,000USD | -678,000USD | -503,000USD | -874,000USD | -528,000USD | -397,000USD | -463,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 0USD | 0USD | 20,000USD | 30,000USD | 25,000USD | 44,000USD |
| Change In Cash | 120,295,000USD | -6,967,000USD | -107,154,000USD | 171,313,000USD | 72,817,000USD | 14,419,000USD | -22,967,000USD | -7,490,000USD |
| Begin Period Cash Flow | 167,806,000USD | 175,609,000USD | 281,927,000USD | 111,450,000USD | 38,633,000USD | 24,214,000USD | 47,181,000USD | 54,671,000USD |
| End Period Cash Flow | 288,101,000USD | 168,642,000USD | 174,773,000USD | 282,763,000USD | 111,450,000USD | 38,633,000USD | 24,214,000USD | 47,181,000USD |
| Unclassified Operating Cash Flow | -7,503,000USD | — | — | -10,691,000USD | -1,852,000USD | -6,589,000USD | — | — |
| Other Cashflows From Financing Activities | — | -1,491,000USD | -400,000USD | — | -854,000USD | 133,000USD | -372,000USD | 375,000USD |
| Unclassified Financing Cash Flow | — | 1,979,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | -2,292,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 2,482,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 105,895,000USD | -56,418,000USD | -55,193,000USD | -92,824,000USD | -265,071,000USD | -278,017,000USD | -236,455,000USD | -215,524,000USD |
| Depreciation | 5,641,000USD | 3,615,000USD | 4,256,000USD | 7,024,000USD | 8,598,000USD | 9,063,000USD | 6,214,000USD | 3,166,000USD |
| Stock Based Compensation | 18,476,000USD | 21,393,000USD | 25,371,000USD | 39,734,000USD | 62,061,000USD | 62,976,000USD | 60,450,000USD | 51,313,000USD |
| Other Non Cash Items | -423,000USD | 7,093,000USD | 3,702,000USD | -183,275,000USD | 26,103,000USD | -20,427,000USD | -23,006,000USD | -43,000USD |
| Change To Account Receivables | -27,099,000USD | -966,000USD | -689,000USD | -2,720,000USD | 1,803,000USD | 6,128,000USD | -15,023,000USD | 1,633,000USD |
| Change In Working Capital | 120,471,000USD | 20,355,000USD | -8,340,000USD | 42,350,000USD | -39,549,000USD | -39,462,000USD | -45,400,000USD | 59,429,000USD |
| Total Cash From Operating Activities | 238,541,000USD | -11,535,000USD | -26,997,000USD | -186,991,000USD | -207,858,000USD | -250,403,000USD | -238,197,000USD | -112,867,000USD |
| Capital Expenditures | -42,000USD | -332,000USD | -2,488,000USD | -572,000USD | -3,406,000USD | -6,616,000USD | -3,176,000USD | -7,240,000USD |
| Free Cash Flow | 238,499,000USD | -11,867,000USD | -29,485,000USD | -187,563,000USD | -211,264,000USD | -257,019,000USD | -241,373,000USD | -120,107,000USD |
| Investments | -105,242,000USD | 12,284,000USD | 7,141,000USD | 54,872,000USD | 127,894,000USD | 17,273,000USD | -84,880,000USD | 163,931,000USD |
| Total Cashflows From Investing Activities | -105,284,000USD | 12,284,000USD | -32,697,000USD | 1,154,009,000USD | 124,494,000USD | 10,721,000USD | -83,051,000USD | 176,708,000USD |
| Total Cash From Financing Activities | -3,248,000USD | -2,497,000USD | -198,933,000USD | -758,806,000USD | 91,860,000USD | 263,085,000USD | 1,291,000USD | 225,200,000USD |
| Sale Purchase Of Stock | -4,034,000USD | -3,104,000USD | -199,551,000USD | -132,280,000USD | -9,061,000USD | -9,749,000USD | -3,173,000USD | -9,807,000USD |
| Issuance Of Capital Stock | 20,000USD | 99,000USD | 0USD | 0USD | 108,180,000USD | 139,915,000USD | 3,474,000USD | 0USD |
| Change In Cash | 130,009,000USD | -1,748,000USD | -258,627,000USD | 208,212,000USD | 8,496,000USD | 23,403,000USD | -319,957,000USD | 289,041,000USD |
| Begin Period Cash Flow | 38,633,000USD | 40,381,000USD | 299,008,000USD | 90,796,000USD | 82,300,000USD | 58,897,000USD | 378,854,000USD | 89,813,000USD |
| End Period Cash Flow | 168,642,000USD | 38,633,000USD | 40,381,000USD | 299,008,000USD | 90,796,000USD | 82,300,000USD | 58,897,000USD | 378,854,000USD |
| Other Cashflows From Financing Activities | -3,248,000USD | 508,000USD | 618,000USD | 5,077,000USD | 3,471,000USD | 764,798,000USD | 6,616,000USD | 5,566,000USD |
| Unclassified Operating Cash Flow | -11,519,000USD | -7,573,000USD | 3,207,000USD | — | — | 15,464,000USD | — | -11,208,000USD |
| Unclassified Financing Cash Flow | 4,034,000USD | — | — | — | 108,180,000USD | -234,759,000USD | — | — |
| Other Cashflows From Investing Activities | — | -2,292,000USD | 1,513,000USD | 1,099,709,000USD | 6,000USD | 64,000USD | 5,000USD | 17,000USD |
| Unclassified Investing Cash Flow | — | 2,624,000USD | -38,863,000USD | — | — | — | 5,000,000USD | 20,000,000USD |
| Change To Inventory | — | — | -8,543,000USD | — | -26,390,000USD | -22,525,000USD | 1,442,000USD | -1,629,000USD |
| Net Borrowings | — | — | 0USD | -631,603,000USD | -10,730,000USD | 127,857,000USD | -2,152,000USD | 229,441,000USD |
| Change To Liabilities | — | — | — | -17,469,000USD | -14,997,000USD | 350,000USD | 4,177,000USD | -16,999,000USD |
| Dividends Paid | — | — | — | -802,000USD | — | -385,062,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 208,212,000USD | 8,496,000USD | 23,403,000USD | -319,957,000USD | 289,041,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 32,500,000 | USD | 0001104659-26-033077 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 74,964,000 | USD | 0001104659-26-033077 |
| FY 2025Yearly · 2025-12-31 | Product | Collaborative Arrangement Revenue | 74,964,000 | USD | 0001104659-26-033077 |
| FY 2025Yearly · 2025-12-31 | Product | Licensing And Milestone — License | 7,500,000 | USD | 0001104659-26-033077 |
| FY 2025Yearly · 2025-12-31 | Product | Milestone | 25,000,000 | USD | 0001104659-26-033077 |
| FY 2024Yearly · 2024-12-31 | Product | Collaborative Arrangement Revenue | 64,381,000 | USD | 0001104659-26-033077 |
| FY 2024Yearly · 2024-12-31 | Product | License | 0 | USD | 0001104659-26-033077 |
| FY 2024Yearly · 2024-12-31 | Product | Milestone | 0 | USD | 0001104659-26-033077 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 223,000 | USD | 0001558370-25-002447 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 57,201,000 | USD | 0001558370-25-002447 |
| FY 2023Yearly · 2023-12-31 | Product | Co Promote Agreement | 57,201,000 | USD | 0001558370-25-002447 |
| FY 2023Yearly · 2023-12-31 | Product | Collaborative Arrangement Revenue | 216,000 | USD | 0001558370-25-002447 |
| FY 2023Yearly · 2023-12-31 | Product | Royalties | 7,000 | USD | 0001558370-25-002447 |
| Q4 2023Quarterly · 2023-12-31 | Product | Co Promote Agreement | 17,360,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Collaborative Arrangement Revenue | 198,000 | USD | Legacy provider |
| Q3 2023Quarterly · 2023-09-30 | Product | Co Promote Agreement | 15,687,000 | USD | 0001558370-24-015602 |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaborative Arrangement Revenue | 6,000 | USD | 0001558370-24-015602 |
| Q2 2023Quarterly · 2023-06-30 | Product | Co Promote Agreement | 13,743,000 | USD | 0001558370-24-011636 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaborative Arrangement Revenue | 6,000 | USD | 0001558370-24-011636 |
| Q1 2023Quarterly · 2023-03-31 | Product | Co Promote Agreement | 10,411,000 | USD | 0001558370-24-008201 |
| Q1 2023Quarterly · 2023-03-31 | Product | Collaborative Arrangement Revenue | 6,000 | USD | 0001558370-24-008201 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 222,000 | USD | 0001558370-24-002267 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 51,124,000 | USD | 0001558370-24-002267 |
| FY 2022Yearly · 2022-12-31 | Product | Co Promote Agreement | 48,624,000 | USD | 0001558370-24-002267 |
| FY 2022Yearly · 2022-12-31 | Product | Collaborative Arrangement Revenue | 192,000 | USD | 0001558370-24-002267 |
| FY 2022Yearly · 2022-12-31 | Product | License | 2,500,000 | USD | 0001558370-24-002267 |
| FY 2022Yearly · 2022-12-31 | Product | Royalties | 30,000 | USD | 0001558370-24-002267 |
| Q3 2022Quarterly · 2022-09-30 | Product | Co Promote Agreement | 12,445,000 | USD | 0001558370-23-018612 |
| Q3 2022Quarterly · 2022-09-30 | Product | Collaborative Arrangement Revenue | 6,000 | USD | 0001558370-23-018612 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 38,000 | USD | 0001558370-23-002595 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 55,273,000 | USD | 0001558370-23-002595 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Arrangement Revenue | 43,848,000 | USD | 0001558370-23-002595 |
| FY 2021Yearly · 2021-12-31 | Product | Yupelri Monotherapy | 82,840,000 | USD | 0001558370-23-002595 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 1,538,000 | USD | 0001558370-23-002595 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 70,319,000 | USD | 0001558370-23-002595 |
| Q3 2020Quarterly · 2020-09-30 | Product | Co Promote Agreement | 10,996,000 | USD | 0001558370-20-013233 |
| Q3 2020Quarterly · 2020-09-30 | Product | Collaborative Arrangement Revenue | 7,261,000 | USD | 0001558370-20-013233 |
| Q2 2020Quarterly · 2020-06-30 | Product | Co Promote Agreement | 9,520,000 | USD | 0001558370-20-010023 |
| Q2 2020Quarterly · 2020-06-30 | Product | Collaborative Arrangement Revenue | 5,488,000 | USD | 0001558370-20-010023 |
| Q1 2020Quarterly · 2020-03-31 | Product | Co Promote Agreement | 11,730,000 | USD | 0001558370-20-006021 |
| Q1 2020Quarterly · 2020-03-31 | Product | Collaborative Arrangement Revenue | 6,632,000 | USD | 0001558370-20-006021 |
| Q1 2020Quarterly · 2020-03-31 | Product | License | 1,500,000 | USD | 0001558370-20-006021 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 18,654,000 | USD | 0001558370-22-002373 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 54,760,000 | USD | 0001558370-22-002373 |
| FY 2018Yearly · 2018-12-31 | Geography | Asia | 14,000 | USD | 0001558370-19-001346 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 11,117,000 | USD | 0001558370-19-001346 |
| FY 2018Yearly · 2018-12-31 | Geography | Other Regions | 0 | USD | 0001558370-19-001346 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 49,239,000 | USD | 0001558370-19-001346 |
| FY 2018Yearly · 2018-12-31 | Product | Co Promote Agreement | 3,275,000 | USD | 0001558370-20-001644 |
| FY 2018Yearly · 2018-12-31 | Product | Collaborative Arrangement Revenue | 41,791,000 | USD | 0001558370-20-001644 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 15,304,000 | USD | 0001558370-20-001644 |
| FY 2017Yearly · 2017-12-31 | Geography | Asia | 5,000 | USD | 0001047469-18-001160 |
| FY 2017Yearly · 2017-12-31 | Geography | Europe | 1,109,000 | USD | 0001047469-18-001160 |
| FY 2017Yearly · 2017-12-31 | Geography | Other Regions | 0 | USD | 0001047469-18-001160 |
| FY 2017Yearly · 2017-12-31 | Geography | United States | 14,272,000 | USD | 0001047469-18-001160 |
| FY 2017Yearly · 2017-12-31 | Product | Collaborative Arrangement Revenue | 598,000 | USD | 0001558370-20-001644 |
| FY 2017Yearly · 2017-12-31 | Product | Product | 14,788,000 | USD | 0001558370-20-001644 |
| FY 2016Yearly · 2016-12-31 | Product | Collaborative Arrangement Revenue | 31,045,000 | USD | 0001558370-19-001346 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 17,603,000 | USD | 0001558370-19-001346 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.